PETER KOMATZ: Open Payments
NPI 1164442836 · JUPITER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 24 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $253 · 2025 $787
Food & beverage: $687Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $272 |
| AstraZeneca Pharmaceuticals LP | 5 | $165 |
| PFIZER INC. | 5 | $110 |
| Daiichi Sankyo Inc. | 2 | $53 |
| ABBVIE INC. | 2 | $52 |
| Genentech USA, Inc. | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $21 |
Products named: XTANDI, DATROWAY, ELAHERE, Vyloy, Enhertu, Columvi, Onivyde, PADCEV.
Industry payments across FL — which companies pay providers there.
